It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AKTS’s FA Score shows that 0 FA rating(s) are green whileLITE’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AKTS’s TA Score shows that 1 TA indicator(s) are bullish while LITE’s TA Score has 3 bullish TA indicator(s).
AKTS (@Biotechnology) experienced а -8.97% price change this week, while LITE (@Telecommunications Equipment) price change was +1.02% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -7.86%. For the same industry, the average monthly price growth was -7.98%, and the average quarterly price growth was -1.75%.
The average weekly price growth across all stocks in the @Telecommunications Equipment industry was -5.80%. For the same industry, the average monthly price growth was +3.89%, and the average quarterly price growth was +60.49%.
AKTS is expected to report earnings on Sep 02, 2026.
LITE is expected to report earnings on Aug 18, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Telecommunications Equipment (-5.80% weekly)The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.
| AKTS | LITE | AKTS / LITE | |
| Capitalization | 1.1B | 67.2B | 2% |
| EBITDA | -76.75M | 552M | -14% |
| Gain YTD | N/A | 134.315 | - |
| P/E Ratio | N/A | 152.05 | - |
| Revenue | 8.28M | 2.49B | 0% |
| Total Cash | 538M | 3.17B | 17% |
| Total Debt | 11.6M | 3.31B | 0% |
AKTS | LITE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 41 Fair valued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 66 | 7 | |
SMR RATING 1..100 | 95 | 43 | |
PRICE GROWTH RATING 1..100 | 34 | 34 | |
P/E GROWTH RATING 1..100 | 100 | 95 | |
SEASONALITY SCORE 1..100 | 49 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AKTS's Valuation (41) in the Telecommunications Equipment industry is somewhat better than the same rating for LITE (85). This means that AKTS’s stock grew somewhat faster than LITE’s over the last 12 months.
LITE's Profit vs Risk Rating (7) in the Telecommunications Equipment industry is somewhat better than the same rating for AKTS (66). This means that LITE’s stock grew somewhat faster than AKTS’s over the last 12 months.
LITE's SMR Rating (43) in the Telecommunications Equipment industry is somewhat better than the same rating for AKTS (95). This means that LITE’s stock grew somewhat faster than AKTS’s over the last 12 months.
LITE's Price Growth Rating (34) in the Telecommunications Equipment industry is in the same range as AKTS (34). This means that LITE’s stock grew similarly to AKTS’s over the last 12 months.
LITE's P/E Growth Rating (95) in the Telecommunications Equipment industry is in the same range as AKTS (100). This means that LITE’s stock grew similarly to AKTS’s over the last 12 months.
| AKTS | LITE | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 77% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Advances ODDS (%) | N/A | 5 days ago 80% |
| Declines ODDS (%) | N/A | 9 days ago 73% |
| BollingerBands ODDS (%) | N/A | 1 day ago 84% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 83% |
A.I.dvisor tells us that AKTS and SPRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTS and SPRY's prices will move in lockstep.
| Ticker / NAME | Correlation To AKTS | 1D Price Change % | ||
|---|---|---|---|---|
| AKTS | 100% | -5.08% | ||
| SPRY - AKTS | 29% Poorly correlated | -5.68% | ||
| CRDO - AKTS | 24% Poorly correlated | -4.88% | ||
| KN - AKTS | 24% Poorly correlated | -5.34% | ||
| LITE - AKTS | 24% Poorly correlated | -8.62% | ||
| ZBRA - AKTS | 23% Poorly correlated | -5.45% | ||
More | ||||